View source for Fig1 Li JofPharmAnal2020 10-2.jpg

==Summary==
{{Information
|Description='''Graphical abstract''' Coronavirus disease 2019 (COVID-19) is a kind of viral pneumonia which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergence of SARS-CoV-2 has been marked as the third introduction of a highly pathogenic coronavirus into the human population after the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) in the twenty-first century. In this minireview, we provide a brief introduction of the general features of SARS-CoV-2 and discuss current knowledge of molecular immune pathogenesis, diagnosis and treatment of COVID-19 on the base of the present understanding of SARS-CoV and MERS-CoV infections, which may be helpful in offering novel insights and potential therapeutic targets for combating the SARS-CoV-2 infection.
|Source={{cite journal |title=Molecular immune pathogenesis and diagnosis of COVID-19 |journal=Journal of Pharmaceutical Analysis |author=Li, X.; Geng, M.; Peng, Y.; Meng, L.; Lu, S. |volume=10 |issue=2 |pages=102–8 |year=2020 |doi=10.1016/j.jpha.2020.03.001}}
|Author=Li, X.; Geng, M.; Peng, Y.; Meng, L.; Lu, S.
|Date=2020
|Permission=[https://creativecommons.org/licenses/by-nc-nd/4.0/ Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International]
}}